Q3 2025 Earnings Call Transcript November 4, 2025 Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Heron Therapeutics Inc ((HRTX)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock ...

Get the latest analysis on Heron Therapeutics (HRTX): current challenges, future outlook, and key growth factors. Click here ...

Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - ...

Heron Therapeutics Inc (HRTX) reports robust sales growth and strategic initiatives, despite facing challenges in gross margins and competitive market dynamics.

Heron Therapeutics, Inc. (Nasdaq: HRTX) ('Heron” or the 'Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Tuesday, ...